Manali Petrochemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 6:54 am

Quick Insight

Manali Petrochemicals Ltd, operating in the petrochemicals-polymers industry, currently trades at a price of 65.1 with a market capitalization of INR 1,120 Cr. The company's P/E stands at 34.2, indicating a relatively high valuation compared to its peers. However, the low ROE of 2.92% and ROCE of 4.83% suggest inefficiencies in capital utilization. With an OPM of 10% and a net profit of 29 Cr, the company faces challenges in generating substantial returns. Furthermore, the high level of borrowings at INR 129 Cr and a CCC of 108 days raise concerns about liquidity management. Investors should closely monitor these metrics to assess the company's financial health and sustainability in the long run.

Competitors of Manali Petrochemicals Ltd

All Competitor Stocks of Manali Petrochemicals Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:20 am

Below is a detailed analysis of the quarterly data for Manali Petrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 235.00 Cr.. The value appears strong and on an upward trend. It has increased from 230.00 Cr. (Mar 2025) to 235.00 Cr., marking an increase of 5.00 Cr..
• For Expenses, as of Jun 2025, the value is 212.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 209.00 Cr. (Mar 2025) to 212.00 Cr., marking an increase of 3.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2025) to 23.00 Cr., marking an increase of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Mar 2025) to 10.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Mar 2025) to 28.00%, marking a decrease of 4.00%.
• For Net Profit, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.83. The value appears strong and on an upward trend. It has increased from 0.63 (Mar 2025) to 0.83, marking an increase of 0.20.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:58 am

Balance Sheet

Last Updated: June 16, 2025, 11:44 am

Below is a detailed analysis of the balance sheet data for Manali Petrochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 86.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 86.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,008.00 Cr.. The value appears strong and on an upward trend. It has increased from 976.00 Cr. (Mar 2024) to 1,008.00 Cr., marking an increase of 32.00 Cr..
• For Borrowings, as of Mar 2025, the value is 129.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 22.00 Cr. (Mar 2024) to 129.00 Cr., marking an increase of 107.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 179.00 Cr.. The value appears to be improving (decreasing). It has decreased from 224.00 Cr. (Mar 2024) to 179.00 Cr., marking a decrease of 45.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,403.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,308.00 Cr. (Mar 2024) to 1,403.00 Cr., marking an increase of 95.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 596.00 Cr.. The value appears strong and on an upward trend. It has increased from 559.00 Cr. (Mar 2024) to 596.00 Cr., marking an increase of 37.00 Cr..
• For CWIP, as of Mar 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 61.00 Cr., marking an increase of 44.00 Cr..
• For Investments, as of Mar 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Mar 2024) to 15.00 Cr., marking a decrease of 14.00 Cr..
• For Other Assets, as of Mar 2025, the value is 731.00 Cr.. The value appears strong and on an upward trend. It has increased from 704.00 Cr. (Mar 2024) to 731.00 Cr., marking an increase of 27.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,403.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,308.00 Cr. (Mar 2024) to 1,403.00 Cr., marking an increase of 95.00 Cr..

Notably, the Reserves (1,008.00 Cr.) exceed the Borrowings (129.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Manali Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 1.12. This value is below the healthy minimum of 5. It has decreased from 2.95 (Mar 23) to 1.12, marking a decrease of 1.83.
• For Diluted EPS (Rs.), as of Mar 24, the value is 1.12. This value is below the healthy minimum of 5. It has decreased from 2.95 (Mar 23) to 1.12, marking a decrease of 1.83.
• For Cash EPS (Rs.), as of Mar 24, the value is 2.59. This value is below the healthy minimum of 3. It has decreased from 4.29 (Mar 23) to 2.59, marking a decrease of 1.70.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 61.73. It has increased from 60.70 (Mar 23) to 61.73, marking an increase of 1.03.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 61.73. It has increased from 60.70 (Mar 23) to 61.73, marking an increase of 1.03.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 60.02. It has decreased from 68.66 (Mar 23) to 60.02, marking a decrease of 8.64.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 4.29. This value is within the healthy range. It has decreased from 5.95 (Mar 23) to 4.29, marking a decrease of 1.66.
• For PBIT / Share (Rs.), as of Mar 24, the value is 2.82. This value is within the healthy range. It has decreased from 4.60 (Mar 23) to 2.82, marking a decrease of 1.78.
• For PBT / Share (Rs.), as of Mar 24, the value is 1.94. This value is within the healthy range. It has decreased from 4.07 (Mar 23) to 1.94, marking a decrease of 2.13.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 1.12. This value is below the healthy minimum of 2. It has decreased from 2.94 (Mar 23) to 1.12, marking a decrease of 1.82.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 1.12. This value is below the healthy minimum of 2. It has decreased from 2.94 (Mar 23) to 1.12, marking a decrease of 1.82.
• For PBDIT Margin (%), as of Mar 24, the value is 7.14. This value is below the healthy minimum of 10. It has decreased from 8.66 (Mar 23) to 7.14, marking a decrease of 1.52.
• For PBIT Margin (%), as of Mar 24, the value is 4.69. This value is below the healthy minimum of 10. It has decreased from 6.70 (Mar 23) to 4.69, marking a decrease of 2.01.
• For PBT Margin (%), as of Mar 24, the value is 3.23. This value is below the healthy minimum of 10. It has decreased from 5.92 (Mar 23) to 3.23, marking a decrease of 2.69.
• For Net Profit Margin (%), as of Mar 24, the value is 1.86. This value is below the healthy minimum of 5. It has decreased from 4.28 (Mar 23) to 1.86, marking a decrease of 2.42.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.86. This value is below the healthy minimum of 8. It has decreased from 4.28 (Mar 23) to 1.86, marking a decrease of 2.42.
• For Return on Networth / Equity (%), as of Mar 24, the value is 1.80. This value is below the healthy minimum of 15. It has decreased from 4.85 (Mar 23) to 1.80, marking a decrease of 3.05.
• For Return on Capital Employeed (%), as of Mar 24, the value is 4.23. This value is below the healthy minimum of 10. It has decreased from 7.02 (Mar 23) to 4.23, marking a decrease of 2.79.
• For Return On Assets (%), as of Mar 24, the value is 1.46. This value is below the healthy minimum of 5. It has decreased from 3.97 (Mar 23) to 1.46, marking a decrease of 2.51.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.79. It has decreased from 0.92 (Mar 23) to 0.79, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 24, the value is 4.31. This value exceeds the healthy maximum of 3. It has decreased from 4.58 (Mar 23) to 4.31, marking a decrease of 0.27.
• For Quick Ratio (X), as of Mar 24, the value is 3.64. This value exceeds the healthy maximum of 2. It has decreased from 3.84 (Mar 23) to 3.64, marking a decrease of 0.20.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 6.65. This value is within the healthy range. It has decreased from 8.86 (Mar 23) to 6.65, marking a decrease of 2.21.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 67.20. This value exceeds the healthy maximum of 50. It has decreased from 84.88 (Mar 23) to 67.20, marking a decrease of 17.68.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 28.99. This value is within the healthy range. It has decreased from 58.24 (Mar 23) to 28.99, marking a decrease of 29.25.
• For Earning Retention Ratio (%), as of Mar 24, the value is 32.80. This value is below the healthy minimum of 40. It has increased from 15.12 (Mar 23) to 32.80, marking an increase of 17.68.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 71.01. This value exceeds the healthy maximum of 70. It has increased from 41.76 (Mar 23) to 71.01, marking an increase of 29.25.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 7.69. This value is within the healthy range. It has decreased from 11.10 (Mar 23) to 7.69, marking a decrease of 3.41.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.58. This value is within the healthy range. It has decreased from 6.50 (Mar 23) to 3.58, marking a decrease of 2.92.
• For Enterprise Value (Cr.), as of Mar 24, the value is 566.51. It has decreased from 656.34 (Mar 23) to 566.51, marking a decrease of 89.83.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.54. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 23) to 0.54, marking a decrease of 0.01.
• For EV / EBITDA (X), as of Mar 24, the value is 7.68. This value is within the healthy range. It has increased from 6.41 (Mar 23) to 7.68, marking an increase of 1.27.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.93. This value is below the healthy minimum of 1. It has increased from 0.87 (Mar 23) to 0.93, marking an increase of 0.06.
• For Retention Ratios (%), as of Mar 24, the value is 32.79. This value is within the healthy range. It has increased from 15.11 (Mar 23) to 32.79, marking an increase of 17.68.
• For Price / BV (X), as of Mar 24, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 0.99 (Mar 23) to 0.91, marking a decrease of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.93. This value is below the healthy minimum of 1. It has increased from 0.87 (Mar 23) to 0.93, marking an increase of 0.06.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.01, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness